Articles in the "Money" category primarily relate to a funding announcement of some sort, typically from an institutional investor such as a venture capital firm, or from a family office, an angel investor, or any combination of private investors. These stories focus mainly on the funding details (who, when, how much, what it will be used for, etc.)
Money
Articles in the "Money" category primarily relate to a funding announcement of some sort, typically from an institutional investor such as a venture capital firm, or from a family office, an angel investor, or any combination of private investors. These stories focus mainly on the funding details (who, when, how much, what it will be used for, etc.)
PathologyWatch has announced $2 million in extension funding of its $5 million series A round that it raised earlier this year. The extension funding comes from life science investors based in Germany, Neue Fund, and Bioventures GmbH. Lateral Capital, BeniVC, and Sky Ventures also participated in the extension round.
In
In the summer of 2018, Richie Stapler and Bruno Lima were trying to sell their remaining smart home fragrance diffusers at the Parade of Homes. They set up a booth in the garage of one of the homes hoping to catch the attention of those exiting the open house. To
PathologyWatch has announced $2 million in extension funding of its $5 million series A round that it raised earlier this year. The extension funding comes from life science investors based in Germany, Neue Fund, and Bioventures GmbH. Lateral Capital, BeniVC, and Sky Ventures also participated in the extension round.
In
PathologyWatch has announced $2 million in extension funding of its $5 million series A round that it raised earlier this year. The extension funding comes from life science investors based in Germany, Neue Fund, and Bioventures GmbH. Lateral Capital, BeniVC, and Sky Ventures also participated in the extension round.
In
PathologyWatch has announced $2 million in extension funding of its $5 million series A round that it raised earlier this year. The extension funding comes from life science investors based in Germany, Neue Fund, and Bioventures GmbH. Lateral Capital, BeniVC, and Sky Ventures also participated in the extension round.
In
In the summer of 2018, Richie Stapler and Bruno Lima were trying to sell their remaining smart home fragrance diffusers at the Parade of Homes. They set up a booth in the garage of one of the homes hoping to catch the attention of those exiting the open house. To
In the summer of 2018, Richie Stapler and Bruno Lima were trying to sell their remaining smart home fragrance diffusers at the Parade of Homes. They set up a booth in the garage of one of the homes hoping to catch the attention of those exiting the open house. To
Vista Equity Partners (“Vista”) today announced that it has agreed to acquire Pluralsight, Inc., the technology workforce development company for $3.5 billion. It is an all-cash transaction acquiring all outstanding shares of Pluralsight common stock for $20.26 per share. The company’s stock dropped precipitously in March
Vista Equity Partners (“Vista”) today announced that it has agreed to acquire Pluralsight, Inc., the technology workforce development company for $3.5 billion. It is an all-cash transaction acquiring all outstanding shares of Pluralsight common stock for $20.26 per share. The company’s stock dropped precipitously in March
Thoma Bravo, a private equity investment firm with offices in Chicago and San Francisco, announced a strategic growth investment in Venafi, the Salt Lake City-based cybersecurity pioneer and inventor of machine identity protection. The transaction values Venafi at $1.15 billion and continues Thoma Bravo’s tradition of acquiring
Thoma Bravo, a private equity investment firm with offices in Chicago and San Francisco, announced a strategic growth investment in Venafi, the Salt Lake City-based cybersecurity pioneer and inventor of machine identity protection. The transaction values Venafi at $1.15 billion and continues Thoma Bravo’s tradition of acquiring
